Reversal Strategies for DOAC-Related Bleeding: Promoting Optimal Use of Reversal Agents
With the emergence of specific reversal strategies for direct-acting oral anticoagulants (DOACs), it is critical for health-system pharmacists to take a leading role in ensuring that these agents are used appropriately. In this educational activity, the faculty review evidence-based protocols and guidelines for the use of DOAC reversal agents and provide strategies for establishing a standardized, evidence-based approach for managing the use of DOAC reversal agents within a health system. Approaches to ensure appropriate use of anticoagulation reversal agents for DOAC-related bleeding are illustrated using case scenarios.
Learning Objectives
- Identify evidence-based protocols and guidelines related to the use of reversal agents for direct-acting oral anticoagulants (DOACS) that standardize clinical practice and address National Patient Safety Goals.
- Identify approaches for ensuring cost-effective use of anticoagulation reversal agents for DOAC-related bleeding.
- Develop a plan for establishing a standardized, evidence-based interprofessional approach for managing the use of DOAC reversal agents within the health system.
Faculty
James S. Kalus, PharmD, FASHP
Director of Pharmacy
Henry Ford Health System
Detroit, Michigan
Jason R. Vilar, Pharm.D., BCCCP
Neurocritical Care Pharmacy Specialist
AdventHealth Orlando
Orlando, Florida
This educational initiative was planned to meet the educational needs of pharmacists in hospitals and health systems involved in the management of bleeding associated with the use of direct-acting oral anticoagulant therapy.
Format:
This online activity consists of slide presentations, active learning, and evaluation. View the system requirements.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
As defined by the Standards of Integrity and Independence definition of ineligible company.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE #: 0204-0000-21-403-H01-P
Release Date: Thursday, April 22, 2021
Expiration Date: Friday, May 13, 2022
Activity Type: Application-based
CE Credits: 1.5 hours
Activity Fee: Free of charge
Participants should claim CE credit for this home-study activity only if they have not claimed credit for the live activity.
To receive CE credit, complete the steps below within 60 days of completing the activity.
- View entire presentation and answer all polling questions.
- Click "Complete Activity" on the last slide to to link to complete the evaluation.
- Verify credits were successfully transferred to CPE Monitor before the ACPE 60-day deadline by checking your NABP eProfile account.
After the 60-day deadline, ASHP will no longer be able to report credit(s).